Non-small-cell lung cancer: how to manage BRAF-mutated disease

• Päätekijät: Giorgia Guaitoli (Tekijä), Lodovica Zullo (Tekijä), Marcello Tiseo (Tekijä), Matthew Dankner (Tekijä), April AN Rose (Tekijä), Francesco Facchinetti (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BioExcel Publishing Ltd, 2023-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

BRAF mutations are reported in about 3-5% of non-small-cell lung cancer (NSCLC), almost exclusively in adenocarcinoma histology, and are classified into three different classes. The segmentation of BRAF mutations into V600 (class 1) and non-V600 (classes 2 and 3) relies on their biological character...